Ad
related to: global pharma plus
Search results
With analysts seeing a likely US recession, here are 4 recession proof stocks to consider | Invezz
Invezz· 6 hours agoAt the beginning of 2024, Citigroup chief US economist predicted in a CNBC interview that the USA...
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Digital Journal· 14 hours agoAlgernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage...services, including use of its proprietary ...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 5 days agoThe study evaluated Opdivo (nivolumab) with concurrent chemoradiotherapy (CCRT) followed by Opdivo ...
GSK's SWIFT trial anthology shows long-acting treatment reduces asthma attacks
FierceBiotech· 19 hours agoIt’s not a double album release, but it’s a close runner-up: the pivotal SWIFT-1 and SWIFT-2 trials have shown that GSK's long acting asthma treatment reduces attacks. Center stage is depemokimab ...
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
The Wall Street Journal· 6 days agoRoche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial,...
Mental health app Innerworld adds membership tier with licensed therapists
VentureBeat· 6 days agoMental health app Innerworld, has launched a new, licensed therapist-led membership plan called...
I’m nearing 65 and am better than ever at my job. With more boomers opting not to retire, I’m not...
Fortune via Yahoo Finance· 4 days agoMultiple studies show that the more connections and engagement one has in life, the longer and...
Another Benefit of Gout Treatment: CV Risk Reduction
Medscape· 6 days agoUrate, the culprit of gout, affects the vasculature in multiple ways that can raise cardiovascular risk (CV) in an individual with gout, and following...
European Midday Briefing:
Morningstar· 6 days agoAfter the inflation report, markets' pricing of Federal Reserve interest rates "seems about where it 'should' be, ahead of the June FOMC in a little under a month's time," Pepperstone said.
No Improvement in OS With Atezolizumab in Relapsing TNBC
Medscape· 6 days agoEarly relapsing disease has again shown the limitations of immunotherapy in triple-negative breast...